Share Information

ViroGates A/S was listed on Nasdaq First North Denmark (VIRO) on 26 June 2018.

Below you will find information about the ViroGates share.

+800

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Quick Triage

A Point of Care Solution

View product

TurbiLatex

For Automated Systems

View product

ELISA Assay

Clinical and Research

View product

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

View recording

New Webinar – View recording

suPARnostic® by ViroGates